NEOADJUVANT TREATMENT BEFORE RADICAL PROSTATECTOMY DECREASES THE NUMBER OF POSITIVE MARGINS IN CT2-T3 BUT HAS NO IMPACT ON PSA PROGRESSION OR SURVIVAL, IN CT2-T3
Lv. Baert et al., NEOADJUVANT TREATMENT BEFORE RADICAL PROSTATECTOMY DECREASES THE NUMBER OF POSITIVE MARGINS IN CT2-T3 BUT HAS NO IMPACT ON PSA PROGRESSION OR SURVIVAL, IN CT2-T3, The Journal of urology, 159(5), 1998, pp. 229-229